Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21152809 | 0.84 | C3AR1 (0.35) | MEN1GAAKMT2A | |
| SCHEMBL4572264 | 0.81 | NPY4R (0.36) | MEN1GAAKMT2A | |
| SCHEMBL26880961 | 0.81 | NPY4R (0.36) | MEN1GAAKMT2A | |
| SCHEMBL24591799 | 0.81 | SIRT6 (0.35) | MEN1GAAKMT2A | |
| SCHEMBL19483434 | 0.78 | ALOX15 (0.36) | MEN1KMT2A | |
| SCHEMBL19483435 | 0.78 | ALOX15 (0.36) | MEN1KMT2A | |
| SCHEMBL19483322 | 0.76 | KDM4E (0.48) | — | |
| SCHEMBL27424230 | 0.76 | POLB (0.41) | MEN1KMT2A | |
| SCHEMBL19483324 | 0.76 | KDM4E (0.48) | — | |
| SCHEMBL22859968 | 0.74 | FOLH1 (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230331770-A1 | ARGININE MODIFICATION AND CONJUGATION METHODS | Encodia, Inc. (US) | 2023-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230331770-A1 | ARGININE MODIFICATION AND CONJUGATION METHODS | ARGLU1, PRMT1, PRMT3 | MEN1 2978/4885GAA 4051/4885KMT2A 1174/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.